News

June 18, 2025

Jasmine Zhong appointed Chief Financial Officer of BIAL

BIAL, an innovative pharmaceutical company, has just announced the appointment of Jasmine Zhong as an Executive Board Member, with the role of Chief Financial Officer, starting in November 2025.

June 3, 2025

BIAL Announces Oral Presentation at GBA1 Meeting 2025

BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156

April 23, 2025

BIAL signs agreement with biotech to speed up research into rare diseases

BIAL, a 100-year-old biopharmaceutical company with a strong commitment to innovation, will be a founding member of the Orphan Therapeutics Accelerator (OTXL), a non-profit biotech

April 10, 2025

BIAL closes centenary celebrations with a documentary

‘BIAL - 100 Years Inspired by the Future’ will be available on the company’s Youtube channel and RTP Play, with the participation of Paulo Portas, Daniel Bessa, José Aranda da Silva and other leading national figures.

April 1, 2025

BIAL launches KYNMOBI(c) in Portugal and Spain

The first sublingual therapy for the on-demand treatment of OFF episodes in Parkinson’s disease

January 7, 2025

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson’s Disease

A hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases

December 3, 2024

BIAL focuses its activity in Mozambique on the commercialisation of medicines

BIAL strengthened the focus of its activity in Mozambique on the commercialisation of medicines

June 28, 2024

Marcelo Rebelo de Sousa honours BIAL's longest-serving employee in the year of the company’s centenary

President of the Republic visits Portuguese pharmaceutical company's factory as part of the conference celebrating its 100th anniversary

May 3, 2024

BIAL launches KYNMOBI® in Germany

The first sublingual therapy for the on-demand treatment of OFF episodes in Parkinson’s disease

Partilhe

Send through